1h Free Analyst Time
The amniotic membrane market is forecasted to grow by USD 2.72 billion during 2023-2028, accelerating at a CAGR of 15.19% during the forecast period. The report on the amniotic membrane market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by extensive use of amniotic membrane transplantation in ophthalmic surgeries, high demand for amniotic membrane in wound repair and reconstruction, and rising demand for biocompatible scaffolds.
The amniotic membrane market is segmented as below:
By End-user
- Hospitals
- Ambulatory surgical centers
- Specialty clinics
- Research and academic institutes
By Type
- Cryopreserved amniotic membrane
- Dehydrated amniotic membrane
By Geography
- North America
- Europe
- Asia
- Rest of World (ROW)
The report on the amniotic membrane market covers the following areas:
- Amniotic membrane market sizing
- Amniotic membrane market forecast
- Amniotic membrane market industry analysis
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.
Table of Contents
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by End-user
7 Market Segmentation by Type
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Opportunity/Restraints
11 Competitive Landscape
12 Competitive Analysis
13 Appendix
List of Exhibits
Executive Summary
The following companies are recognized as the key players in the global amniotic membrane market: Amnio Technology LLC, Applied Biologics LLC, BIOHEALING SRO, Celularity Inc., Flower Orthopedics Corp., Human Regenerative Technologies LLC, Integra Lifesciences Corp., Katena Products Inc., Merakris Therapeutics Inc., MiMedx Group Inc., Next Biosciences Pty Ltd., NuVision Biotherapies Ltd, Organogenesis Holdings Inc., Orthofix Medical Inc., Reea carewell products, Skye Biologics Holdings LLC, Stryker Corp., Surgenex LLC, SURGITECH INNOVATION, and TissueTech Inc..Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is growing reimbursement coverage for new products."
According to the report, one of the major drivers for this market is the extensive use of amniotic membrane transplantation in ophthalmic surgeries.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Amnio Technology LLC
- Applied Biologics LLC
- BIOHEALING SRO
- Celularity Inc.
- Flower Orthopedics Corp.
- Human Regenerative Technologies LLC
- Integra Lifesciences Corp.
- Katena Products Inc.
- Merakris Therapeutics Inc.
- MiMedx Group Inc.
- Next Biosciences Pty Ltd.
- NuVision Biotherapies Ltd
- Organogenesis Holdings Inc.
- Orthofix Medical Inc.
- Reea carewell products
- Skye Biologics Holdings LLC
- Stryker Corp.
- Surgenex LLC
- SURGITECH INNOVATION
- TissueTech Inc.
